Systemic Treatment of Non-Small Cell Lung Cancer

— —

Giuseppe Giaccone (Chief of Medical Oncology, National Cancer Institute (NCI) of the National Institutes of Health (NIH), Bethesda, Maryland, USA)

Systemic Treatment of Non-Small Cell Lung Cancer

Giuseppe Giaccone (Chief of Medical Oncology, National Cancer Institute (NCI) of the National Institutes of Health (NIH), Bethesda, Maryland, USA)

$83.95

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Oxford University Press
22 May 2012

Oncology

Series: Oxford Oncology Library

Lung cancer is the leading cause of cancer mortality worldwide, and non-small cell lung cancer (NSCLC) accounts for about 85% of all cases of lung cancer. Most patients present with advanced disease and five-year survival is low at about 15%. Surgery is the main treatment for early stage disease. If patients are deemed inoperable, systemic chemotherapy is considered. For patients with locally advanced disease, multimodality therapy is administered where chemotherapy is given in combination with definitive radiation therapy or surgery in selected cases. Cytotoxic chemotherapy regimens mainly consist of a platinum doublet. Biologic agents are increasingly being incorporated into treatment regimens. This pocketbook summarises the latest evidence-based and practical information on the use of systemic therapies in the management of non-small cell lung cancer (NSCLC), for early stage, locally advanced, and metastatic disease. Including contributions from leading thoracic oncologists from North America and Europe, the book covers the range of therapies currently available to clinicians including cytotoxic chemotherapy, biologic therapies, and other novel agents. This book will serve as an invaluable reference for all health care professionals involved in the management of patients with NSCLC.

Edited by: Giuseppe Giaccone (Chief of Medical Oncology National Cancer Institute (NCI) of the National Institutes of Health (NIH) Bethesda Maryland USA)
Imprint: Oxford University Press
Country of Publication: United Kingdom
Dimensions: Height: 197mm, Width: 131mm, Spine: 8mm
Weight: 144g
ISBN: 9780199580484
ISBN 10: 0199580480
Series: Oxford Oncology Library
Pages: 128
Publication Date: 22 May 2012
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

Giuseppe Giaccone, M.D., Ph.D. is an internationally recognized expert in the field of lung cancer and developmental therapeutics. Dr. Giaccone received his M.D. cum laude from the University of Torino Medical School in 1980, followed by training in clinical oncology and internal medicine, which he completed at the University of Torino in 1988. He spent the next two years in the NCI's Medical Oncology Branch. Following his training at the NCI, Dr. Giaccone received his Ph.D. from the Free University Medical Center in Amsterdam, The Netherlands. He then served as a senior medical oncologist at the Medical Center from 1990 to 2000, when he was appointed Professor of Medical Oncology. Dr. Giaccone became Head of the Center's Department of Medical Oncology in 2003. Dr. Giaccone has published more than 400 peer-reviewed papers and contributed to more than 30 book chapters. He has also played a major role in the European Organization for Research and Treatment of Cancer (EORTC).

AUSTRALIA-WIDE LOW FLAT RATE $9.90

Systemic Treatment of Non-Small Cell Lung Cancer

Giuseppe Giaccone (Chief of Medical Oncology, National Cancer Institute (NCI) of the National Institutes of Health (NIH), Bethesda, Maryland, USA)

$83.95

Paperback

See Also

Contact Abbeys

Contact Galaxy

Contact Language

Contact Us

About ABBEY'S